NCT02562482: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT02562482 |
|---|---|
| Title | Phase 2 Randomized, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of a Chikungunya Virus-Like Particle Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Nov. 18, 2015 |
| Completion date | March 6, 2018 |
| Required reporting date | March 6, 2019, midnight |
| Actual reporting date | March 5, 2019 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |